Europe
Pharnext SA announced the appointment of Susanne Dorn, M.Sc., as Chief Regulatory Officer and Serge Fitoussi, M.D., M.Sc., as Chief Medical Officer
After a vigorous inaugural year, the wave-parting Poseidon pharmaceutical ocean-freight network will be laying bare its unique “PLUG & PLAY” operating model at the IQPC Temperature Controlled Logistics (TCL) Conference at Twickenham Stadium, London, from 28th to 31st January 2019.
MDxHealth SA today issued a preliminary update on its 2018 financial results.
Auditdata announces that founder and CEO of Auditdata will step down and incoming CEO Kurt Bager will take over at the end of January 2019
After four years at AstraZeneca, Chief Medical Officer Sean Bohen will be leaving the company following an organizational shakeup at the U.K.-based pharma giant. Bohen joined AstraZeneca from Genentech in 2015 and also serves as head of global medicines development.
Artificial intelligence technology has an established home in drug design for many developers. Now, researchers are seeing it as a potential tool in driving therapeutic choices in the treatment of ovarian cancer.
As 2019 gets underway for the biopharma industry, more companies are increasing their reliance on the use of artificial intelligence as part of their drug discovery process.
The new DEINOVE website displays an updated presentation of DEINOVE’s corporate activities and identity
Ensuring strong medical skills and identification of diseases - especially life-threatening conditions - is a top concern for all participants in the United States healthcare system
Biopharma companies strengthen the leadership teams during the annual J.P. Morgan Healthcare Conference.
PRESS RELEASES